Skip to main content

Table 1 Prevalence rate of HBV & HCV positivity among HIV+ patient

From: Survey of both hepatitis B virus (HBsAg) and hepatitis C virus (HCV-Ab) coinfection among HIV positive patients

  

HBsAg+

Anti-HCV+

Double Positive

Variable

N (Percent)

N

P

N

P

N

P

Total

391(100%)

57(14.5%)

 

282 (72%)

 

31 (7.9%)

 

Sex

  

<0.001

 

<0.001

 

<0.001

   Male

358 (91.6%)

40(11.2%)

 

274(76.5%)

 

24 (6.7%)

 

   Female

33 (8.4%)

17(51.5%)

 

8 (24.3%)

 

7 (21.2%)

 

Age

  

0.013

 

<0.001

 

<0.001

   ≤ 30

140 (35.8%)

18(12.9%)

 

108 (77.2%)

 

8 (5.7%)

 

   31-50

204 (52.1%)

27(13.2%)

 

151 (74%)

 

18 (8.9%)

 

   ≥ 50

47 (12%)

12(25.5%)

 

23 (48.9%)

 

5 (10.6%)

 

Marital status

  

<0.001

 

<0.001

 

<0.001

   Single

195 (49.8%)

14(7.2%)

 

160 (82%)

 

11(5.7%)

 

   Married

166 (42.4%)

40(24%)

 

99 (59.7%)

 

18 (10.6%)

 

   Other

30 (7.6%)

3 (10%)

 

23 (76.7%)

 

2 (6.7%)

 

Risk Factor

  

<0.001

 

<0.001

 

<0.001

   IDU

202 (51.6%)

12 (5.9%)

 

172 (85.2%)

 

8 (3.1%)

 

   Sexual

11 (2.8%)

4 (3.4%)

 

3 (27.3%)

 

1 (9%)

 

   Transfusion

12 (3%)

0 (0%)

 

12 (100%)

 

0 (0%)

 

   Sex & IDU

56 (14.3%)

6 (10.7%)

 

36 (64.3%)

 

13(23.2%)

 

   Pregnant

5 (1.2%)

2 (40%)

 

0 (0%)

 

0 (0%)

 

   Other

105 (26.8%)

33(31.5%)

 

59 (56.2%)

 

9 (8.6%)

 

Occupation

  

<0.001

 

<0.001

 

<0.001

   Unemployed

221 (56.5%)

16 (7.2%)

 

174 (78.7%)

 

15 (6.8%)

 

   Self employed

63 (16.1%)

8 (12.7%)

 

47 (74.6%)

 

4 (6.3%)

 

   Worker

42)10.7%)

6 (14.3%)

 

33 (78.6%)

 

3 (7.2%)

 

   Employee

3 (0.7%)

1) 33.3%)

 

2 (66.7%)

 

0) 0%)

 

   housewife

32 (8.1%)

16 (50%)

 

8) 25%)

 

7 (21.9%)

 

   Farmer

4 (1%)

4 (100%)

 

0 (0%)

 

0 (0%)

 

   Student

12 (3%)

3 (25%)

 

9 (75%)

 

0 (0%)

 

   Driver

10 (2.5%)

2 (20%)

 

6 (60%)

 

20 (20%)

 

   Other

4 (1%)

1 (25%)

 

3 (75%)

 

0 (0%)

 
  1. HBsAg: HBV surface antigen, anti-HCV: antibody against HCV, N: number of patients, p: p-value, IDU: Injection drugs users